The Limited Times

Now you can see non-English news...

Covid-19: still many questions about the vaccination of children under 12

2021-09-17T14:46:24.225Z


DECRYPTION - Studies are underway to develop a vaccine for the youngest but no decision has been made.


In France, 12-17 year olds can already receive the Comirnaty vaccine from Pfizer / BioNTech or Spikevax from Moderna, authorized for adolescents since June 15.

But no decision has yet been made regarding the under-12s.

And for good reason, the results of the two main pediatric clinical trials in progress have not yet been sent to the European Medicines Agency (EMA), responsible for evaluating the marketing authorization applications (MA) of vaccines against Covid for the entire European Union.

To discover

  • Covid-19: the third vaccine dose, instructions for use

Read also

Vaccination of children: the reluctant French

The Pfizer / BioNTech trial, launched in June, which will include up to 4,500 patients aged 6 months to 11 years, in the United States, Finland, Spain and Poland, and that of Moderna ( more than 12,000 participants).

Pfizer's results for the 5-11 age group should be sent to the Food and Drug Administration in September-October for possible emergency marketing authorization. end of

This article is for subscribers only.

You have 81% left to discover.

Pushing back the limits of science is also freedom.

Continue reading your article for € 1 the first month

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-09-17

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.